Surveillance study following the completion of "Peretinoin Phase2/3 study"

Surveillance study following the completion of "Peretinoin Phase2/3 study" - Cohort study with Peretinoin for HCC(Curative therapy)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000006728

Enrollment

392

Registered

2011-11-15

Start date

2012-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma with HCV-RNA positive

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who entered in NIK-333 PhaseII/III trial. (Ref.JAPIC Clinical Trials Information: JapicCTI-060250)

Exclusion criteria

Exclusion criteria: "HBs" positive patient

Design outcomes

Primary

Measure	Time frame
Overall Survival	—

Countries

Japan

Contacts

Public ContactToshihiko Ohnishi

Social insurance Alliance Shimonoseki Kohsei Hospital Clinical Study Support Center

koseih_4@koseihp.jp083-231-5811

Outcome results